Gavi-eligible countries applying for Gavi funding support for the introduction of pneumococcal vaccine need to follow Gavi's standard application procedures.

In addition, in June 2010, the Gavi Board approved the grandfathering of the AMC such that all countries that were eligible for Gavi support at the time of signature of the AMC legal agreements – in June 2009 – are still able to access the Gavi pneumococcal vaccine price at the AMC terms and conditions.

Countries that have transitioned or are no longer eligible for other forms of Gavi support can request access to the Gavi pneumococcal vaccine price using the transitioned countries’ guidelines and price request form available here. As of the start of 2018, these countries are:

  • Bhutan
  • Cuba
  • Indonesia
  • India
  • Sri Lanka
  • Timor Leste
  • Ukraine

It's an excellent example of how innovation and technology together can produce life-saving advances and make them available to people who need them around the world."  

Bill Gates, co-chair of the Bill & Melinda Gates Foundation

More on this topic

Last updated: 28 Feb 2020

Subscribe to our newsletter